Insulet Price to Sales Ratio 2010-2024 | PODD
Historical PS ratio values for Insulet (PODD) over the last 10 years. The current P/S ratio for Insulet as of May 02, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Insulet P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-05-02 |
257.01 |
|
9.16 |
| 2024-12-31 |
261.07 |
$28.05 |
9.31 |
| 2024-09-30 |
232.75 |
$26.89 |
8.66 |
| 2024-06-30 |
201.80 |
$25.41 |
7.94 |
| 2024-03-31 |
171.40 |
$24.44 |
7.01 |
| 2023-12-31 |
216.98 |
$23.56 |
9.21 |
| 2023-09-30 |
159.49 |
$21.93 |
7.27 |
| 2023-06-30 |
288.34 |
$20.96 |
13.76 |
| 2023-03-31 |
318.96 |
$19.62 |
16.25 |
| 2022-12-31 |
294.39 |
$18.74 |
15.71 |
| 2022-09-30 |
229.40 |
$17.94 |
12.79 |
| 2022-06-30 |
217.94 |
$16.99 |
12.83 |
| 2022-03-31 |
266.39 |
$16.62 |
16.03 |
| 2021-12-31 |
266.07 |
$16.21 |
16.42 |
| 2021-09-30 |
284.23 |
$15.45 |
18.39 |
| 2021-06-30 |
274.51 |
$15.00 |
18.31 |
| 2021-03-31 |
260.92 |
$14.50 |
17.99 |
| 2020-12-31 |
255.63 |
$13.83 |
18.48 |
| 2020-09-30 |
236.59 |
$13.46 |
17.57 |
| 2020-06-30 |
194.26 |
$13.04 |
14.89 |
| 2020-03-31 |
165.68 |
$12.47 |
13.28 |
| 2019-12-31 |
171.20 |
$11.93 |
14.35 |
| 2019-09-30 |
164.93 |
$11.27 |
14.63 |
| 2019-06-30 |
119.38 |
$10.66 |
11.19 |
| 2019-03-31 |
95.09 |
$9.90 |
9.61 |
| 2018-12-31 |
79.32 |
$9.40 |
8.44 |
| 2018-09-30 |
105.95 |
$8.95 |
11.84 |
| 2018-06-30 |
85.70 |
$8.58 |
9.99 |
| 2018-03-31 |
86.68 |
$8.36 |
10.37 |
| 2017-12-31 |
69.00 |
$8.01 |
8.62 |
| 2017-09-30 |
55.08 |
$7.56 |
7.28 |
| 2017-06-30 |
51.31 |
$7.12 |
7.21 |
| 2017-03-31 |
43.09 |
$6.75 |
6.38 |
| 2016-12-31 |
37.68 |
$6.41 |
5.87 |
| 2016-09-30 |
40.94 |
$6.08 |
6.73 |
| 2016-06-30 |
30.24 |
$5.68 |
5.32 |
| 2016-03-31 |
33.16 |
$5.22 |
6.35 |
| 2015-12-31 |
37.81 |
$4.65 |
8.13 |
| 2015-09-30 |
25.91 |
$3.45 |
7.52 |
| 2015-06-30 |
30.99 |
$3.53 |
8.77 |
| 2015-03-31 |
33.35 |
$3.77 |
8.85 |
| 2014-12-31 |
46.06 |
$4.17 |
11.04 |
| 2014-09-30 |
36.85 |
$5.17 |
7.13 |
| 2014-06-30 |
39.67 |
$4.95 |
8.02 |
| 2014-03-31 |
47.42 |
$4.76 |
9.96 |
| 2013-12-31 |
37.10 |
$4.59 |
8.09 |
| 2013-09-30 |
36.24 |
$4.53 |
8.01 |
| 2013-06-30 |
31.41 |
$4.54 |
6.91 |
| 2013-03-31 |
25.86 |
$4.49 |
5.75 |
| 2012-12-31 |
21.22 |
$4.42 |
4.80 |
| 2012-09-30 |
21.58 |
$4.22 |
5.11 |
| 2012-06-30 |
21.37 |
$4.02 |
5.31 |
| 2012-03-31 |
19.14 |
$3.65 |
5.24 |
| 2011-12-31 |
18.83 |
$3.27 |
5.76 |
| 2011-09-30 |
15.26 |
$2.96 |
5.16 |
| 2011-06-30 |
22.17 |
$2.65 |
8.37 |
| 2011-03-31 |
20.62 |
$2.55 |
8.07 |
| 2010-12-31 |
15.50 |
$2.48 |
6.24 |
| 2010-09-30 |
14.14 |
$2.46 |
5.74 |
| 2010-06-30 |
15.05 |
$2.50 |
6.03 |
| 2010-03-31 |
15.09 |
$2.42 |
6.23 |
| 2009-12-31 |
14.28 |
$2.32 |
6.15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$18.084B |
$2.072B |
|
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
|
